about
Cre-lox-regulated conditional RNA interference from transgenesWidespread regulatory activity of vertebrate microRNA* speciesGermline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humansTargeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clustersThe CRISPR revolution and its impact on cancer researchCapture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signalingRestoration of p53 function leads to tumour regression in vivoSomatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.Role of the miR-17∼92 cluster family in cerebellar and medulloblastoma development.In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA.miR than meets the eye.microRNA-34a regulates neurite outgrowth, spinal morphology, and functionRapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries.Embryonic stem cell miRNAs and their roles in development and disease.Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic CholangiocarcinomaThe microRNA-17-92 family of microRNA clusters in development and disease.The present and future of genome editing in cancer research.Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspectivep66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells.The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter.An allelic series of miR-17 ∼ 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron.Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility.MicroRNAs and cancer: short RNAs go a long way.In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system.Intact p53-dependent responses in miR-34-deficient mice.A cryptic targeting signal induces isoform-specific localization of p46Shc to mitochondria.Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.Control of T(FH) differentiation by a microRNA cluster.Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.Expression in T-cells of the proapoptotic protein p66SHC is controlled by promoter demethylation.NORAD: Defender of the Genome.A new role for miR-182 in DNA repairCharacterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing
P50
Q24564248-B691BB81-B7FF-4EA9-B2ED-3B388CD11399Q24595841-53EF8662-14AE-4176-8FD1-EE7643EB76C5Q24635323-0B364851-3801-4046-99A5-538AD7848849Q24645192-81F93930-FD93-4BCC-84BC-F85B59C213CFQ26824997-CBB79AEC-FB68-4D4F-9292-58E9BD724F5CQ28477912-2A31CDF0-675D-4B9D-B08D-5CD80DBE6BD1Q29618727-B89CD71A-400F-4A7C-819A-ECD90F22CD83Q33899971-2638F725-1176-4661-896C-A0E38D222993Q34131951-C9FC98BA-6B27-4220-A06E-C9B715DF12C3Q35031404-47F90B50-D517-4D44-A5E9-4AF33F38FA26Q35193208-63842FE2-5BCA-4BB8-9FD4-497E83AAB4DEQ35641380-8505178F-73B2-44CF-9F8C-F30285780E10Q35747399-B6686530-D072-4AF7-8D7C-28FD8FDA35B9Q36186002-1B288DAF-6074-4E5F-8AF4-D0EB59BD9B9FQ37296946-8F7CD8CF-4001-4F57-9C9C-B530F5C64AE9Q38014608-8CAF1F48-2077-499B-9D8A-8125D694DF00Q38840267-603FCF70-702C-41E9-AFB7-B33556517DE0Q38926441-855F42FB-341C-4543-916F-829C57AC0216Q40583604-329839F7-E21C-436E-BF71-0ED4A454239DQ40738889-55638CEB-20BA-4B12-9AF3-FA7278FA8B7AQ40883914-B92100F2-6191-4A1E-B08C-4759DE4A732AQ41061594-ADE23D3F-A2E6-445E-9922-F7E5399A72DBQ41906288-D9264034-BA68-478B-9395-13AB829BF41BQ42183080-4601A453-9A30-4355-81ED-26C3F2800474Q42251432-B43419AD-F90F-47AC-B516-A023C76C8BEEQ42834816-B23F3AA2-7B34-4025-AA77-91DC6C1CF90AQ47917570-66C6F699-BBA1-4955-A734-C104419F7DC4Q47980819-73B7EE8D-5C09-4DA5-BC89-39264C268E0DQ52723228-A6474154-62B2-4EB4-AF19-0AD6489EC7A9Q53603069-31AAE660-9647-4C3B-9D7C-A48C8143CDF6Q54201626-CD25B80C-D150-4F13-8CB1-C60BD9D054ADQ83264145-229A6AAE-8B2A-487D-BFA9-ECC7368CC95FQ90568300-8B6DD1CA-ED05-4C9B-8F5E-71DDF01EDC95
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea Ventura
@ast
Andrea Ventura
@en
Andrea Ventura
@es
Andrea Ventura
@fr
Andrea Ventura
@nl
Andrea Ventura
@sl
type
label
Andrea Ventura
@ast
Andrea Ventura
@en
Andrea Ventura
@es
Andrea Ventura
@fr
Andrea Ventura
@nl
Andrea Ventura
@sl
prefLabel
Andrea Ventura
@ast
Andrea Ventura
@en
Andrea Ventura
@es
Andrea Ventura
@fr
Andrea Ventura
@nl
Andrea Ventura
@sl
P106
P1153
7102874116
P31
P496
0000-0003-4320-9907